Which drugs are most likely to be approved in Choroidal Disease?

Choroidal Disease disease is an indication for drug development with over 40 pipeline drugs currently active according to GlobalData.

Risk Adjusted Net Present Value: What is the current valuation of AnaptysBio’s Imsidolimab

The revenue for Imsidolimab is expected to reach an annual total of $14 mn by 2037 in the US based off GlobalData’s Expiry Model. The

August 28, 2023

PolyPeptide signs scientific collaboration agreement – Biotech Investments

PolyPeptide Group / Key word(s): Partnership/ESG PolyPeptide signs scientific collaboration agreement 31.10.2023 / 07:00 CET/CEST Media Release PolyPeptide signs scientific collaboration agreement Strasbourg, 31

November 1, 2023

Social media misinformation is scaring women about birth control

In a viral TikTok, a woman in the emergency room shares a message questioning why so many women in their 30s struggle with cancer and

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.